Blog
  • Omnichannel
  • Oncology
  • Conferences
  • Media Tracking
  • Ferma.AI
  • Launch Excellence
  • HCP-PT
  • Talent Community

Launch

A collection of 5 posts

ZoomRx Announces Acquisition of Vivisum Partners, Reinforcing Strategic Consulting Capabilities for Developing Life Sciences Brands
ZoomRx

ZoomRx Announces Acquisition of Vivisum Partners, Reinforcing Strategic Consulting Capabilities for Developing Life Sciences Brands

Global life sciences consulting firm ZoomRx today announced the acquisition of Vivisum Partners, a boutique market research company specializing in customized and comprehensive market research to support pharmaceutical brand launch. The acquisition reinforces

  • ZoomRx
    ZoomRx
2 min read
HCP-Patient Conversations: Real-World Narratives Shaping Post-Launch Brand Strategies
HCP-Pt

HCP-Patient Conversations: Real-World Narratives Shaping Post-Launch Brand Strategies

Shaping a Patient Centric Launch Strategy Launching pharma brands today is high stakes, often with a great deal of uncertainty on the success of their initial roll-out. Expectations are high for a seamless

  • Vinny Valant
    Vinny Valant
  • Avinash Krishnan
6 min read
ZoomRx Announces Launch of ZoomRx TV Tracking
ZoomRX TV

ZoomRx Announces Launch of ZoomRx TV Tracking

The First TV Media Measurement and Optimization Platform Designed for Life Sciences. Cambridge, Massachusetts, November 29, 2023 – Global life sciences consulting firm ZoomRx is set to transform how life sciences brands monitor and

  • ZoomRx
    ZoomRx
4 min read
Revolutionizing Medical Information with Generative AI
Ferma Engine

Revolutionizing Medical Information with Generative AI

In the ever-evolving world of life sciences, medical information teams often find themselves at the forefront of this change, grappling with an increasing volume of intricate clinical inquiries. Despite this growing influx of

  • ZoomRx
    ZoomRx
2 min read
Transforming Post-HCT Care for Blood Cancer Patients - Insights from Oncologists
Launch Excellence

Transforming Post-HCT Care for Blood Cancer Patients - Insights from Oncologists

Introduction: Omisirge, the revolutionary stem cell therapy developed by Gamida Cell, has recently received FDA approval and is poised to revolutionize the post-HCT (hematopoietic stem cell transplantation) journey for patients with blood cancers.

  • Karni Medh
    Karni Medh
2 min read

All rights reserved ZoomRx - 2020.   Privacy Policy


HOME
PERSPECTIVES
PANELISTS
CAREERS